Zeliadt, Steven B.; Penson, David F. - In: PharmacoEconomics 25 (2007) 4, pp. 309-327
The resources devoted to managing metastatic prostate cancer are enormous, yet little attention has been given to directly measuring the economic consequences of treatment alternatives. The purpose of this article was to evaluate the pharmacoeconomics of available treatments for metastatic...